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Allergic bronchopulmonary aspergillosis (ABPA) 
was first reported in England during 19521, since 
then a number of cases have been diagnosed and 
reported from many countries2,3. This pulmonary 
disorder arises from an allergic response to multiple 
antigens expressed by aspergillus fumigatus4. In 
temperate climates, aspergillus is one of the 
common indoor allergens responsible for asthma. 
Swimming pools and basements that are moist and 
humid for prolonged periods of time harbor these 
fungi. ABPA may develop in individuals with 
episodic obstructive lung disease such as asthma 
and cystic fibrosis that produce thick tenacious 
sputum5. The factors underlying the development of 
ABPA remain unclear. The role of genetic factors, 
mucous quality, preactivation of epithelial cells and 
the extent to which this activation facilitates the 
development of aspergillus spores into hyphae, 
bronchial penetration of aspergillus, the immune 
response and bronchiolar inflammation that leads to 
destruction are not yet fully understood6. The 
condition under which aspergillus fumigatus 
colonizes the respiratory tract in patients 
developing ABPA is a factor associated with the 
pathophysiology of the disease7.  
Improved diagnostic methods and awareness 
have led to recent reports of higher prevalence of 
ABPA in patients suffering from chronic asthma (1-
40%) and 7-15% of cystic fibrosis (CF) 
patients8,9,10. ABPA leads to poorly controlled 
asthma with pulmonary exacerbations and 
detrimental consequences; dependence on oral-
corticosteroids increases the risk for secondary 
infections11. In rare cases, ABPA disease has also 
been reported to complicate other lung diseases 
including idiopathic bronchiectasis, chronic 
obstructive pulmonary disease (~38%)6,12,13. 
Moreover, ABPA has also been reported in patients 
with pulmonary aspergilloma and chronic 
necrotizing pulmonary aspergillosis14. The 
prevalence of AF hypersensitivity is even higher in 
patients with acute severe asthma (~51%)15. 
Aspergillus fumigatus-sensitized asthmatic patients 
have been reported to have poor lung function16,17.  
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Background: Allergic bronchopulmonary aspergillosis (ABPA) occurs in 
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It has been noted that proteases activate 
protease activated receptors (PARs) which are G-
protein coupled receptors present on the airway 
cells and other cells such as mast cells, eosinophils, 
neutrophils, macrophages and lymphocytes18. To 
date, four PARs have been identified; PAR-2 is the 
most important in allergic airway disease owing to 
its increased expression on the airways of asthmatic 
patients19. Interestingly, injured airway epithelial 
cells also secrete trypsin, a PAR-2 agonist that 
further aggravates allergic inflammatory responses. 
Genetic association studies have shown that 
polymorphisms in the SP-A and MBL gene lead to 
a predisposition to develop ABPA19,20. ABPA can 
occur at any age in individuals with atopy. Patients 
have recurrent episodes of asthma exacerbation 
with wheezing and chest infiltrates. They have 
systemic manifestations such as fever, malaise and 
anorexia. Sputum production is characterized by 
chunks of green or beige colored sputum plugs. 
Mucus plugging results in partial obstruction of 




This study was carried out at the Pulmonology Unit, 
Pediatric Department and at Allergy and 
Immunology Unit, Microbiology Department, 
Zagazig University during the period from 
September 2008 to October 2011. 
This study included 80 asthmatic children 
diagnosed according to National Asthma Education 
and Prevention Programme 22. Their ages ranged 
from 3 to 14 years. The severity of asthma was 
classified according to GINA guidelines for asthma 
severity23,24. 
Asthmatic children were divided into: Group 
(1): Fifty atopic children according to positive 
family history, history of atopy to a specific 
allergen, positive skin prick test to one or more 
allergens, eosinophilia and elevated IgE level and 
Group (2): Thirty non- atopics diagnosed by 
exclusion of atopy, precipitation of asthma by 
exercise, cold air or hormonal changes.  Informed 
consents were taken from the parents or care-givers 
of all children. 
Exclusion criteria were: Children with parasitic 
infestations, or those taking any medication other 
than anti-asthma drugs and children with 
immunocompromised disorders.  
The following were done: History taking to 
find if there was positive family history of asthma, 
assess asthma severity and differentiate between 
atopic and non-atopic asthmatics. Thorough clinical 
examination to exclude any other cause of distress 
as chest infection. Pulmonary function tests to 
prove the diagnosis and assess the severity of 
asthma as FEV1 ≥80%: intermittent or mild asthma, 
60-80%: moderate asthma, <60%: severe asthma25. 
The apparatus used was master screen Viasys 
Health Care GmBh, Germany.  
Stool analysis was done to exclude parasitic 
infestations. Chest x-rays were obtained as needed. 
Skin prick test for all children, absolute 
eosinophilic count, serum total IgE and specific 
serum anti fumigatus IgE and IgG were done. 
All sera were tested for AF specific antibodies 
using UniCAP 100 assay (CAP; Pharmacia/Upjohn, 
Kalamazoo, MI). A.fumigatus total extract and 
recombinant AF allergens Asp f1, f2, f3, f4, and f6 
coupled ImmunoCAPs were used to detect specific 
IgE in the sera, according to the protocol 
recommended by the manufacturer. An 
ImmunoCAP class of 1 or more (35 mgA/L) was 
considered to be positive. The same lot of 
ImmunoCAPs and reagents were used for all the 
study26,27,28.  
Allergy skin test 
Reagents: Allergen 8 Coca's extracted allergens 
were used, saline (0.9% NaCl) was used as a 
negative control and histamine (histamine acid 
phosphate 1 mg/ml) was used as a positive control. 
For the intradermal skin test, 1/1000 W/V (100 µl 
of 1/10 W/V of diluted extract to 9900 µl saline) of 
diluted extract was used 29. The allergens used were: 
house dust, human hair, smoke, wool, cotton, mixed 
fungi (Aspergillus niger, Aspergillus flavus, and 
Aspergillus fumigatus), mixed pollens and hay dust. 
The procedure of skin intradermal test: The 
skin of the volar surface of the forearm was cleaned 
and marked, 0.1 ml of 1/1000 dilution of each 
extract, negative and positive controls were injected 
intradermally; after15 minutes the tested sites were 
inspected. Fully developed erythema and wheal 
reactions were remeasured after 30 minutes. The 
mean wheal size was represented as (X + x)/2 (X is 
the maximum diameter, and x is the perpendicular 
diameter). Mean wheal size of greater than or equal 
to 3 mm was regarded as positive30. No 
antihistamines were taken in the last 48 hours prior 
to the test, so as not to affect the result. 
Serum Total IgE 
It was measured using RIDASCREEN® 
Spezifisches IgE kit by EIA technique31. Analytical 
sensitivity and specificity of the kit were 0.24 IU/ml 
and 91.2% respectively. 
 
Statistical analysis 
Data were presented as mean ± standard deviation 
(X± SD), median and range or percentage (%). All 
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statistical comparisons were performed using the 
student's t test, X2, Z test, Fisher's exact test and 
Kruskal-Wallis H test. Data were checked and 
analyzed using Statistical Package of Social 
Science (SPSS) for windows version 8. P values 
less than 0.05 were considered significant. 
 
RESULTS 
Both atopic and non-atopic asthmatic children were 
age and sex matched. Skin prick test positive cases 
to anti fumigatus (SPT AF) was present only in the 
atopic group where 16/50 of atopic cases were 
positive which represented (32%). Total IgE, 
specific IgE (AF), IgG (AF) and eosinophilic count 
were statistically higher in the atopic group (table 
1). SPT AF positive cases were associated with 
prolonged duration of asthma.  History of steroid 
dependency was higher in AF positive cases. FEV1 
was lower in AF positive cases than in AF negative 
ones (table 2). Wheal diameter was larger with 
increased serum IgE (AF) titer , but no relation 
between wheal diameter and  either IgG (AF) or 
total IgE (table 3).The percentage of atopic children 
sensitive to mixed fungi represented 40% (table 4). 
 
 
Table 1. Demographic and laboratory data of atopic and non-atopic children. 










0.15 t = 1.45 6.4 ± 2.5 7.2± 2.3 Age (yr) 
0.89 X2 = 0.02 
11     55% 
9     45% 
28     55% 
22     45% 
Sex Male  
 Female  
0.000** X2 = 12.0 0 16 Skin prick test positive cases (n) 





IgE   
ng/ml 





IgE (AF)  
mg/L 





IgG (AF)  
mg/L 





Absolute eosinophilic count/µL 




Table 2. History and clinical evaluation of atopic cases both with positive and 
negative SPT for A. fumigatus. 











0.000** t = 12.9 5.1 9.15 Duration of asthma (yr) 
0.02* t = 4.96 10/34 10/16 History of steroid dependency (n) 
0.02* t = 5.12 16/34 13/16 Severe asthma    (n)  
0.000** t = 6.3 75± 9.5% 57± 8.9% FEV1 % of predicted 
0.66 Fisher's 
exact 
30/34 13/16 Allergic rhinitis (n) 
0.51 Fisher's 
exact 
25/34 10/16 Eczema (n) 
0.58 Fisher's 
exact 
32/34 14/16 Family history of asthma (n) 
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Table 3. Wheal diameter in relation to immunoglobulin levels in 




























 > 7 mm (n = 4) 
0.51 5.7 0.05 Kruskal-Wallis test 




Table 4.  Frequency of positive skin test to the common 
allergens in atopic patients. 
PercentageNumber of 
patients 
Type of allergens 
40% 20 Mixed fungi 
32% 16 Aspergillus fumigatus 
48% 24 House dust 
8% 4 Human hair 
52% 26 Smoke 
18% 9 Wool 
26% 13 Cotton 
76% 38 Mixed pollens 
58% 29 Hay dust 
 
DISCUSSION 
Fungi are ubiquitous and responsible for causing a 
broad spectrum of type I-IV hypersensitivity 
diseases6. Recent epidemiologic studies clearly 
outline the link between fungal sensitization and 
exacerbations of allergic asthma, leading to 
increased morbidity and mortality7,32. 
Our study was conducted on 50 atopic and 30 
non-atopic asthmatics. We found that skin prick test 
positive cases for aspergillus fumigatus was 
positive in 16 out of 50 (32%) atopic children, but 
no positive cases were found among non-atopic 
group. Knusten et al8 reported that 40% of patients 
suffering from chronic asthma had ABPA. This 
might be due to improved diagnostic methods and 
awareness that have led to recent reports of higher 
prevalence of ABPA. However another study7 
found that airway colonization by fungi, 
predominantly by Aspergillus fumigatus, had been 
demonstrated in airways of both subjects with and 
without asthma. They suspected that ABPA is a 
florid hypersensitivity reaction to A. fumigatus and 
the colonization in the airways was reported in up 
to 8% of patients with asthma and 13% with cystic 
fibrosis (CF). SPT for A. fumigatus was negative in 
all non- atopics as it was considered a 
hypersensitivity reaction33. The absolute 
eosinophilic count and total IgE were higher in the 
atopic group; many other studies reported the same 
results5,6,9,23. 
Specific immunoglobulin to AF (IgE and IgG 
AF) were higher in the atopic group as ABPA was 
considered a hypersensitivity disorder33. We found 
that A. fumigatus positive cases were significantly 
associated with prolonged duration of asthma and 
lower FEV1 than negative ones. It is not possible to 
tell whether the association between A. fumigatus–
IgE sensitization and reduced lung function is 
causal; it is possible that sensitization is related to 
long-term colonization in the airways of asthma, 
which may occur preferentially in damaged 
airways34. This would be consistent with the 
observation that A. fumigatus-IgE-sensitized 
patients with asthma had a longer duration of 
asthma, as has been previously shown. Another 
study by Hargreave and Nair35 reported that, there 
was a clear association between asthma duration 
and A. fumigatus–IgE sensitization, suggesting that 
the longer the duration of asthma, the more likely A. 
fumigatus sensitization would occur. 
Bronchiectasis, which again could be a 
consequence of colonization, did not explain the 
association between A. fumigatus–IgE and reduced 
FEV1. It is therefore probable that A. fumigatus is at 
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least responsible for the development of fixed 
airflow obstruction in asthma, either as a result of 
the effects of its many toxins on the bronchial 
mucosa, or through stimulating a vigorous and 
persistent inflammatory reaction35.  
As regards positive skin test to the common 
allergens in atopic patients we found that mixed 
fungi represented 40% of atopic asthmatics. 
Maccario et al.36 evaluated the skin prick test 
responses and showed that nearly 34% of resistant 
asthma was due to fungal infections. Nouer et al.37 
reported that aspergillus fumigatus was the reason 
for nearly 29% of resistant asthmatic cases. Another 
study reported that over 80% of Aspergillus-related 
conditions, such as extrinsic allergic alveolitis, 
asthma, allergic sinusitis, chronic eosinophilic 
pneumonia, hypersensitivity pneumonitis, and 
allergic bronchopulmonary aspergillosis (ABPA) 
were most frequently caused by A. fumigatus38.  
We found that A. fumigatus represented 80% 
of fungal infections. Another study succeeded to 
grow AF fungi in 30% only of mixed fungal 
infection in atopic children39. The difference in the 
results may be due to different weather conditions; 
as humid air is a cofactor for AF fungi to grow40. 
In conclusion; aspergillus fumigatus can play a 
crucial role in inducing atopic asthma in children. 
Evaluation of AF sensitization especially in 
severely asthmatic patients may be helpful in 
diagnosis and for the planning of management. 
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